Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Shaffer

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Nature Biotechnology|October 29, 2025
Author Correction: Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Nature Biotechnology|October 7, 2025
Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Journal of Medicinal Chemistry|July 21, 2022
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical InteractionsGuozhang Xu, Zhijie Liu, Xinkang Wang, et al.
Journal of Medicinal Chemistry|June 27, 2024
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus InfectionsBart Kesteleyn, Florence Herschke, Nicolas Darville, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Journal of Medicinal Chemistry|August 18, 2025
In Pursuit of Best-in-Class MCL-1 Inhibitors: Discovery of Highly Potent 1,4-Indoyl Macrocycles with Favorable Physicochemical PropertiesIngrid Adriana Velter, William Lento, Aldo Peschiulli, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 8, 2026
Identification of an Inhaled Pulmonary Selective PDGFR Inhibitor with Sustained Target EngagementGlenn Marsboom, Tianbao Lu, Zhigang Hong, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Nature Biotechnology|October 29, 2025
Author Correction: Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Nature Biotechnology|October 7, 2025
Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Journal of Medicinal Chemistry|July 21, 2022
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical InteractionsGuozhang Xu, Zhijie Liu, Xinkang Wang, et al.
Journal of Medicinal Chemistry|June 27, 2024
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus InfectionsBart Kesteleyn, Florence Herschke, Nicolas Darville, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Journal of Medicinal Chemistry|August 18, 2025
In Pursuit of Best-in-Class MCL-1 Inhibitors: Discovery of Highly Potent 1,4-Indoyl Macrocycles with Favorable Physicochemical PropertiesIngrid Adriana Velter, William Lento, Aldo Peschiulli, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 8, 2026
Identification of an Inhaled Pulmonary Selective PDGFR Inhibitor with Sustained Target EngagementGlenn Marsboom, Tianbao Lu, Zhigang Hong, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Pageof 3